Post-Marketing Surveillance Study of Micardis® Plus in Patients With Hypertension

Boehringer Ingelheim

Status: Completed

Conditions: Hypertension

Treatments: Drug: Micardis® plus

Study type: Observational

Funder types: Industry

Identifiers

NCT02238275

502.390

Details and patient eligibility

About

Study to evaluate efficacy and tolerability of Micardis® plus under usual daily-practice prescribing-conditions

Enrollment: 8,135 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult (Age >= 18 years) males and females for whom a medical antihypertensive therapy is indicated

Exclusion criteria

• Age < 18 years

Trial design

8,135 participants in 1 patient group

Patients with hypertension

Treatment:

Drug: Micardis® plus